Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 18.34%7.57B | 17.40%4.82B | 25.52%2.27B | 27.59%8.7B | 29.51%6.4B | 4.11B | 1.8B | 9.43%6.82B | 4.94B | -0.86%6.23B |
| Operating revenue | 18.34%7.57B | 17.40%4.82B | 25.52%2.27B | 27.59%8.7B | 29.51%6.4B | --4.11B | --1.8B | 9.43%6.82B | --4.94B | -0.86%6.23B |
| Other operating revenue | ---- | -3.53%902.51K | ---- | 85.73%3.02M | ---- | --935.52K | ---- | 12.14%1.63M | ---- | -12.70%1.45M |
| Total operating cost | 18.35%7.39B | 18.09%4.71B | 25.36%2.22B | 27.44%8.51B | 6.25B | 3.99B | 1.77B | 9.04%6.68B | 0.39%6.12B | |
| Operating cost | 18.34%7.27B | 18.05%4.63B | 25.35%2.18B | 27.11%8.37B | --6.14B | --3.92B | --1.74B | 8.87%6.59B | ---- | 0.42%6.05B |
| Operating tax surcharges | -39.42%7.02M | -52.23%4.51M | 34.58%2.04M | 151.25%15.06M | --11.59M | --9.44M | --1.51M | 46.57%5.99M | ---- | -4.30%4.09M |
| Operating expense | 5.43%13.39M | 7.62%9.15M | 87.32%4.84M | 43.78%16.75M | --12.7M | --8.5M | --2.58M | 30.55%11.65M | ---- | -25.06%8.92M |
| Administration expense | 33.20%40.6M | 45.83%30.55M | 24.57%13.87M | 26.48%40.62M | --30.48M | --20.95M | --11.13M | 18.80%32.11M | ---- | 13.74%27.03M |
| Financial expense | -6.64%24.56M | -0.47%14.75M | 6.58%7.27M | 95.01%34.03M | --26.3M | --14.82M | --6.82M | 22.66%17.45M | ---- | -22.94%14.23M |
| -Interest expense (Financial expense) | 26.09%29.35M | 39.28%19.05M | 48.21%9.24M | 87.06%33.89M | --23.28M | --13.68M | --6.23M | 48.82%18.12M | ---- | -17.63%12.17M |
| -Interest Income (Financial expense) | -163.82%-5.55M | -246.36%-4M | -1,113.73%-2.44M | -84.38%-4.82M | ---2.1M | ---1.15M | ---200.84K | -98.28%-2.61M | ---- | -39.61%-1.32M |
| Research and development | 63.84%37.84M | 56.87%24.02M | 23.28%12.9M | 31.96%34.55M | --23.1M | --15.31M | --10.46M | 19.28%26.18M | ---- | 11.50%21.95M |
| Credit Impairment Loss | -4.65%-4.06M | 13.61%-2.1M | -3.19%-2.18M | -98.75%-6.19M | ---3.88M | ---2.44M | ---2.12M | -401.99%-3.11M | ---- | 80.20%-620.39K |
| Asset Impairment Loss | 80.13%-1.09M | 86.20%-760.1K | 28.27%-494.36K | -270.90%-7.55M | ---5.47M | ---5.51M | ---689.19K | 89.39%-2.04M | ---- | -19.49%-19.18M |
| Other net revenue | 44.71%20.91M | 302.63%17.56M | -100.68%-38.49K | -13.11%21.98M | 14.45M | 4.36M | 5.64M | 126.21%25.3M | 0 | 1,029.29%11.18M |
| Fair value change income | -136.15%-346.87K | -91.93%179.14K | 24.13%-97.94K | 440.91%1.99M | --959.55K | --2.22M | ---129.1K | 6.70%367.07K | ---- | 150.57%344.01K |
| Invest income | 157.74%313.9K | -8.74%-1.61M | -122.07%-1.56M | 75.93%-1.01M | ---543.69K | ---1.48M | ---700.24K | 24.94%-4.21M | ---- | -2.87%-5.61M |
| Asset deal income | -112.03%-35.67K | -110.13%-30.03K | ---- | 302.05%432.99K | --296.39K | --296.39K | --12.29K | -507.88%-214.3K | ---- | --52.54K |
| Other revenue | 13.15%26.12M | 94.18%21.88M | -53.65%4.29M | -0.54%34.32M | --23.09M | --11.27M | --9.26M | -4.68%34.5M | ---- | 50.10%36.2M |
| Operating profit | 20.55%196.13M | 4.87%126.5M | 13.80%41.74M | 27.48%209.13M | 30.16%162.69M | 120.62M | 36.67M | 40.82%164.04M | 124.99M | -36.01%116.49M |
| Add:Non operating Income | -55.66%94.68K | -57.03%91.7K | 34.55%97.62K | -23.57%220.64K | --213.51K | --213.39K | --72.55K | 146.10%288.66K | ---- | -61.62%117.29K |
| Less:Non operating expense | -58.26%700.75K | -68.96%448.66K | 6.34%33.16K | 296.87%1.8M | --1.68M | --1.45M | --31.18K | 194.43%453.24K | ---- | -51.20%153.94K |
| Total profit | 21.27%195.52M | 5.66%126.15M | 13.85%41.8M | 26.65%207.55M | 29.20%161.23M | 119.39M | 36.72M | 40.72%163.88M | 124.79M | -36.03%116.45M |
| Less:Income tax cost | 17.68%30.28M | -2.40%20.56M | 40.19%5.26M | 41.24%31.24M | --25.73M | --21.06M | --3.75M | 95.53%22.12M | ---- | -67.02%11.31M |
| Net profit | 21.95%165.24M | 7.38%105.59M | 10.85%36.54M | 24.37%176.31M | 26.57%135.49M | 98.33M | 32.96M | 34.83%141.76M | 107.05M | -28.83%105.14M |
| Net profit from continuing operation | 21.95%165.24M | 7.38%105.59M | 10.85%36.54M | 24.37%176.31M | --135.49M | --98.33M | --32.96M | 34.83%141.76M | ---- | -28.83%105.14M |
| Net profit of parent company owners | 21.95%165.24M | 7.38%105.59M | 10.85%36.54M | 24.37%176.31M | 26.57%135.49M | --98.33M | --32.96M | 34.83%141.76M | --107.05M | -28.83%105.14M |
| Earning per share | ||||||||||
| Basic earning per share | 0.00%1.24 | -7.78%0.83 | 10.00%0.33 | 23.85%1.61 | --1.24 | --0.9 | --0.3 | 35.42%1.3 | ---- | -30.94%0.96 |
| Diluted earning per share | 0.00%1.24 | -7.78%0.83 | 10.00%0.33 | 23.85%1.61 | --1.24 | --0.9 | --0.3 | --1.3 | ---- | ---- |
| Other composite income | 15.05K | -36.94K | ||||||||
| Other composite income of parent company owners | --15.05K | ---36.94K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total composite income | 21.97%165.25M | 7.35%105.55M | 10.85%36.54M | 24.37%176.31M | 135.49M | 98.33M | 32.96M | 34.83%141.76M | -28.83%105.14M | |
| Total composite income of parent company owners | 21.97%165.25M | 7.35%105.55M | 10.85%36.54M | 24.37%176.31M | --135.49M | --98.33M | --32.96M | 34.83%141.76M | ---- | -28.83%105.14M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | Unqualified opinion |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | Rong Cheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.